These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11126389)

  • 21. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers.
    Chen G; Manji HK
    Curr Opin Psychiatry; 2006 May; 19(3):313-23. PubMed ID: 16612219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Depression and treatment. Apoptosis, neuroplasticity and antidepressants].
    Arantes-Gonçalves F; Coelho R
    Acta Med Port; 2006; 19(1):9-20. PubMed ID: 16987439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of neurotrophic factors in the etiology and treatment of mood disorders.
    Duman RS
    Neuromolecular Med; 2004; 5(1):11-25. PubMed ID: 15001809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular signalling pathways and mood disorders.
    Fišar Z; Hroudová J
    Folia Biol (Praha); 2010; 56(4):135-48. PubMed ID: 20974046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular plasticity and resilience and the pathophysiology of severe mood disorders.
    Charney DS; Dejesus G; Manji HK
    Dialogues Clin Neurosci; 2004 Jun; 6(2):217-25. PubMed ID: 22033657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglia in neuronal plasticity: Influence of stress.
    Delpech JC; Madore C; Nadjar A; Joffre C; Wohleb ES; Layé S
    Neuropharmacology; 2015 Sep; 96(Pt A):19-28. PubMed ID: 25582288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients.
    Moore GJ; Cortese BM; Glitz DA; Zajac-Benitez C; Quiroz JA; Uhde TW; Drevets WC; Manji HK
    J Clin Psychiatry; 2009 Apr; 70(5):699-705. PubMed ID: 19389332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell pathology in mood disorders.
    Rajkowska G
    Semin Clin Neuropsychiatry; 2002 Oct; 7(4):281-92. PubMed ID: 12382210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
    J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stress, depression, and neuroplasticity: a convergence of mechanisms.
    Pittenger C; Duman RS
    Neuropsychopharmacology; 2008 Jan; 33(1):88-109. PubMed ID: 17851537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers.
    Zhou R; Gray NA; Yuan P; Li X; Chen J; Chen G; Damschroder-Williams P; Du J; Zhang L; Manji HK
    J Neurosci; 2005 May; 25(18):4493-502. PubMed ID: 15872096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells.
    Rajkowska G
    Biol Psychiatry; 2000 Oct; 48(8):766-77. PubMed ID: 11063973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multiaxial evaluation of the pathophysiology of mood disorder and therapeutic mechanisms of clinical drugs by neuronal plasticity and neuronal load].
    Omata N; Mizuno T; Mitsuya H; Wada Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):231-6. PubMed ID: 25069263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Finding the intracellular signaling pathways affected by mood disorder treatments.
    Coyle JT; Duman RS
    Neuron; 2003 Apr; 38(2):157-60. PubMed ID: 12718851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal plasticity and survival in mood disorders.
    Duman RS; Malberg J; Nakagawa S; D'Sa C
    Biol Psychiatry; 2000 Oct; 48(8):732-9. PubMed ID: 11063970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Psychiatric disorders from a perspective of glia].
    Takebayashi M
    Seishin Shinkeigaku Zasshi; 2013; 115(12):1186-93. PubMed ID: 24601091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview.
    Tardito D; Perez J; Tiraboschi E; Musazzi L; Racagni G; Popoli M
    Pharmacol Rev; 2006 Mar; 58(1):115-34. PubMed ID: 16507885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synaptic plasticity and mood disorders.
    Duman RS
    Mol Psychiatry; 2002; 7 Suppl 1():S29-34. PubMed ID: 11986993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Hypoxic Injury in Mood Disorder.
    Zhao F; Yang J; Cui R
    Neural Plast; 2017; 2017():6986983. PubMed ID: 28717522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuronal plasticity: a link between stress and mood disorders.
    Calabrese F; Molteni R; Racagni G; Riva MA
    Psychoneuroendocrinology; 2009 Dec; 34 Suppl 1():S208-16. PubMed ID: 19541429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.